Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

Thu, 16th Sep 2021 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

EXANE BNP RAISES STANDARD CHARTERED TO 'NEUTRAL' (UNDERPERFORM)

----------

DEUTSCHE BANK CUTS SHELL PRICE TARGET TO 1,871 (1,937) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES BP PRICE TARGET TO 320 (313) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ANGLO AMERICAN PRICE TARGET TO 3,600 (3,700) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS ANTOFAGASTA PRICE TARGET TO 1,310 (1,320) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS RIO TINTO PRICE TARGET TO 6,000 (6,600) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BHP GROUP PRICE TARGET TO 2,200 (2,400) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES GLENCORE PRICE TARGET TO 440 (420) PENCE - 'BUY'

----------

RBC RAISES GLENCORE PRICE TARGET TO 400 (360) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES GLENCORE PRICE TARGET TO 430 (390) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS UNILEVER TO 'HOLD' (BUY) - PRICE TARGET 4,600 (4,800) PENCE

----------

JPMORGAN RAISES JD SPORTS FASHION TARGET TO 1,350 (1,300) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

CREDIT SUISSE RAISES REDROW PRICE TARGET TO 745 (640) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES REDROW PRICE TARGET TO 800 (673) PENCE - 'BUY'

----------

BARCLAYS RAISES REDROW PRICE TARGET TO 820 (810) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES REDROW PRICE TARGET TO 850 (790) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES DRAX GROUP PRICE TARGET TO 960 (550) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES VESUVIUS PRICE TARGET TO 760 (685) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BRITVIC TO 'HOLD' ('BUY') - TARGET 950 PENCE

----------

BERENBERG RAISES TRUSTPILOT PRICE TARGET TO 440 (430) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES SOUTH32 PRICE TARGET TO 200 (185) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SOUTH32 PRICE TARGET TO 195 (165) PENCE - 'HOLD'

----------

BERENBERG CUTS PAN AFRICAN RESOURCES PRICE TARGET TO 25 (29) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 860 (935) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES KEYWORDS STUDIOS TARGET TO 3,550 (3,200) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES KEYWORDS STUDIOS PRICE TARGET TO 3,700 (3,450) PENCE - 'BUY'

----------

BARCLAYS CUTS FEVERTREE DRINKS PRICE TARGET TO 2,400 (2,500) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES FEVERTREE DRINKS PRICE TARGET TO 2,200 (2,100) PENCE - 'HOLD'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2020 09:07

Clinigen FY revenues continue to rise, profit growth slowed by Covid-19

(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its Foscavir drug.

Read more
13 Jul 2020 16:29

Clinigen gets orphan drug designation for 'aldesleukin' in the US

(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for 'aldesleukin', in the treatment of amyotrophic lateral sclerosis (ALS).

Read more
13 Jul 2020 13:48

Monday broker round-up

(Sharecast News) - Kingfisher: RBC Capital Markets reiterates outperform with a target price of 275.0p

Read more
13 Jul 2020 08:41

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Read more
14 Jun 2020 19:22

Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen

(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian

Read more
28 May 2020 13:34

Thursday broker round-up

(Sharecast News) - Provident Financial: RBC Capital Markets reiterates sector performer with a target price of 195p.

Read more
28 May 2020 09:37

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Read more
26 May 2020 17:50

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Read more
12 May 2020 10:37

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

Read more
16 Apr 2020 12:00

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Read more
24 Mar 2020 16:00

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

Read more
20 Mar 2020 09:49

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

Read more
18 Mar 2020 13:42

Wednesday broker round-up

(Sharecast News) - Polypipe: Deutsche Bank upgrades to buy with a target price of 550p.

Read more
12 Mar 2020 16:05

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
11 Mar 2020 13:37

Wednesday broker round-up

(Sharecast News) - Clinigen Group: Liberum upgrades to buy with a target price of 780.0p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.